Jerome M. Hershman

17.6k total citations · 1 hit paper
352 papers, 13.1k citations indexed

About

Jerome M. Hershman is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Reproductive Medicine. According to data from OpenAlex, Jerome M. Hershman has authored 352 papers receiving a total of 13.1k indexed citations (citations by other indexed papers that have themselves been cited), including 243 papers in Endocrinology, Diabetes and Metabolism, 60 papers in Molecular Biology and 41 papers in Reproductive Medicine. Recurrent topics in Jerome M. Hershman's work include Thyroid Disorders and Treatments (179 papers), Growth Hormone and Insulin-like Growth Factors (76 papers) and Thyroid Cancer Diagnosis and Treatment (72 papers). Jerome M. Hershman is often cited by papers focused on Thyroid Disorders and Treatments (179 papers), Growth Hormone and Insulin-like Growth Factors (76 papers) and Thyroid Cancer Diagnosis and Treatment (72 papers). Jerome M. Hershman collaborates with scholars based in United States, Japan and Italy. Jerome M. Hershman's co-authors include A. EUGENE PEKARY, Harold E. Carlson, Gregory A. Brent, Clark T. Sawin, Xuan-Ping Pang, A E Pekary, John E. Morley, James R. Sowers, James A. Pittman and Masayoshi Yoshimura and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Biological Chemistry.

In The Last Decade

Jerome M. Hershman

333 papers receiving 12.1k citations

Hit Papers

Subclinical Thyroid Disease 2004 2026 2011 2018 2004 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Subclinical Thyroid Disease
    2004 1.3k citations Jerome M. Hershman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerome M. Hershman United States 60 8.2k 2.8k 1.2k 1.1k 1.1k 352 13.1k
Lesley Rees United Kingdom 69 4.8k 0.6× 2.5k 0.9× 893 0.7× 2.1k 2.0× 863 0.8× 359 15.1k
KAZUO SHIZUME Japan 53 4.8k 0.6× 2.6k 0.9× 956 0.8× 747 0.7× 475 0.4× 388 9.5k
H. Guyda Canada 46 4.4k 0.5× 2.1k 0.8× 998 0.8× 590 0.5× 803 0.8× 183 7.8k
Scott A. Rivkees United States 56 4.5k 0.5× 3.2k 1.1× 945 0.8× 1.6k 1.5× 319 0.3× 191 12.1k
E. Chester Ridgway United States 56 9.0k 1.1× 2.2k 0.8× 1.7k 1.4× 303 0.3× 1.3k 1.2× 188 11.7k
Luca Persani Italy 58 5.7k 0.7× 4.4k 1.6× 2.6k 2.1× 592 0.5× 1.6k 1.5× 371 12.3k
Robert D. Utiger United States 54 5.3k 0.6× 1.7k 0.6× 696 0.6× 1.2k 1.1× 883 0.8× 136 9.3k
Akira Shimatsu Japan 53 4.6k 0.6× 2.6k 0.9× 804 0.7× 936 0.9× 509 0.5× 331 12.5k
Gregory A. Brent United States 52 7.5k 0.9× 3.5k 1.3× 2.5k 2.0× 359 0.3× 425 0.4× 143 12.2k
Sidney H. Ingbar United States 57 7.9k 1.0× 3.0k 1.1× 1.2k 0.9× 425 0.4× 342 0.3× 292 12.8k

Countries citing papers authored by Jerome M. Hershman

Since Specialization
Citations

This map shows the geographic impact of Jerome M. Hershman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerome M. Hershman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerome M. Hershman more than expected).

Fields of papers citing papers by Jerome M. Hershman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerome M. Hershman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerome M. Hershman. The network helps show where Jerome M. Hershman may publish in the future.

Co-authorship network of co-authors of Jerome M. Hershman

This figure shows the co-authorship network connecting the top 25 collaborators of Jerome M. Hershman. A scholar is included among the top collaborators of Jerome M. Hershman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerome M. Hershman. Jerome M. Hershman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hershman, Jerome M. & Paolo Beck‐Peccoz. (2023). Discoveries Around the Hypothalamic–Pituitary–Thyroid Axis. Thyroid. 33(7). 785–790. 10 indexed citations
2.
Hershman, Jerome M.. (2018). Alemtuzumab, a Monoclonal Antibody to CD52, Frequently Causes Graves’ Disease. Clinical Thyroidology. 30(8). 353–355.
3.
Hershman, Jerome M.. (2017). Multifocality Is Not an Independent Risk Factor for Recurrence of Papillary Thyroid Cancer. Clinical Thyroidology. 29(11). 437–439. 2 indexed citations
4.
Hershman, Jerome M.. (2017). Thyroid Cancer Incidence and Mortality Are Increasing. Clinical Thyroidology. 29(6). 221–223. 2 indexed citations
5.
Hershman, Jerome M.. (2017). Levothyroxine Therapy of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy Does Not Improve Cognitive Function in the Offspring. Clinical Thyroidology. 29(4). 132–135. 4 indexed citations
6.
Hershman, Jerome M.. (2017). A Deiodinase 2 Polymorphism May Lower Serum T 3 and Tissue T 3 in Levothyroxine-Treated Patients. Clinical Thyroidology. 29(9). 338–340. 2 indexed citations
7.
8.
Hershman, Jerome M.. (2017). The Increased Incidence of Thyroid Cancer Is Worldwide. Clinical Thyroidology. 29(1). 11–12. 3 indexed citations
9.
Hershman, Jerome M.. (2015). Painless Thyroiditis with Thyrotoxicosis or Hypothyroidism May Develop in Patients Receiving Programmed Death 1 Receptor Immunotherapy. Clinical Thyroidology. 27(7). 185–186. 1 indexed citations
10.
Hershman, Jerome M.. (2015). Estrogen and Progesterone Receptors in Papillary Thyroid Cancers Do Not Affect Outcome. Clinical Thyroidology. 27(6). 155–157. 2 indexed citations
11.
Hershman, Jerome M.. (2015). A Prevalent Polymorphism in Type 2 Deiodinase May Disrupt Brain Function and Contribute to Neurodegenerative Processes. Clinical Thyroidology. 27(5). 118–120. 1 indexed citations
12.
Hershman, Jerome M.. (2015). Lenvatinib Increases Progression-free Survival in Patients with Metastatic Radioiodine-Resistant Differentiated Thyroid Cancer. Clinical Thyroidology. 27(4). 86–88. 1 indexed citations
13.
Beaudenon‐Huibregtse, Sylvie, Erik K. Alexander, Richard Guttler, et al.. (2014). Centralized Molecular Testing for Oncogenic Gene Mutations Complements the Local Cytopathologic Diagnosis of Thyroid Nodules. Thyroid. 24(10). 1479–1487. 95 indexed citations
14.
Hershman, Jerome M., et al.. (2014). Hashimoto's Thyroiditis Does Not Predispose Patients to Differentiated Thyroid Cancer. Clinical Thyroidology. 26(9). 227–229. 2 indexed citations
15.
16.
Hershman, Jerome M.. (2014). Should We Avoid Diagnosing Small Papillary Thyroid Cancers?. Clinical Thyroidology. 26(12). 311–312. 1 indexed citations
17.
18.
Hershman, Jerome M.. (2014). Sorafenib Prolongs Progression-free Survival of Metastatic Differentiated Thyroid Cancer Patients 
by Five Months. Clinical Thyroidology. 26(7). 180–182. 1 indexed citations
19.
Marion, Kenneth M., et al.. (2010). Stability of Recombinant Human Thyrotropin Potency Based on Bioassay in FRTL-5 Cells. Thyroid. 20(10). 1139–1143. 10 indexed citations
20.
Yanagisawa, M., Carol J. Mirell, & Jerome M. Hershman. (1988). Triiodothyronine Inhibits Phorbol Ester-Induced Thyrotropin Release From Elutriated Bovine Thyrotrophs*. Endocrinology. 122(5). 2121–2126. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lesley Rees Breakdown of academic impact, for papers by KAZUO SHIZUME Breakdown of academic impact, for papers by H. Guyda Breakdown of academic impact, for papers by Scott A. Rivkees Breakdown of academic impact, for papers by E. Chester Ridgway Breakdown of academic impact, for papers by Luca Persani Breakdown of academic impact, for papers by Robert D. Utiger Breakdown of academic impact, for papers by Akira Shimatsu Breakdown of academic impact, for papers by Gregory A. Brent Breakdown of academic impact, for papers by Sidney H. Ingbar
Rankless by CCL
2026